echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Pfizer vaccine is questioned, the effective rate against the "Delta" variant has dropped from 94% to 64%

    Pfizer vaccine is questioned, the effective rate against the "Delta" variant has dropped from 94% to 64%

    • Last Update: 2021-08-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, a mutant strain of new coronary pneumonia called "Delta" has sounded new alarms about the global epidemic.
    Compared with the original virus and early mutant strains, the Delta mutation has the strongest transmission power, short incubation period, and disease progression.
    Soon, it has now spread to more than 90 countries or regions, making the global epidemic prevention and control more difficult
    .

    Although various localities have introduced corresponding epidemic prevention and control plans, the epidemic situation in some countries is still not optimistic, including Israel, which has the world's highest vaccination rate today
    .


    It is understood that as a leader in the global vaccination rate, more than 23% of the people in Israel have now been vaccinated by Pfizer.


    Recently, a preliminary study by the Israeli Ministry of Health showed that Delta not only has a strong transmission capacity, but also weakens the effect of the vaccine.
    The effective rate of the fully vaccinated BioNTech&Pfizer mRNA vaccine against Delta mutant strains has dropped from 94% to 64%!

    But some other experts hold different opinions
    .


    They said that this latest study is not consistent with the British evaluation standards.




    The chairman of the Israeli expert group, Ran Balicer, said that 85% of Israeli adults have been vaccinated
    .


    "But the rate of these breakthrough cases that we have seen makes some people think that they are beyond expectations.
    This indicates that the vaccine's effectiveness for mild diseases may be reduced, but it has no effect on serious diseases


    In the context of the global epidemic counterattack, this research has sent a signal to the outside world that with the large-scale spread of the delta mutant virus, the new crown vaccines of all countries will be tested by the mutant strains
    .

    Reference materials:

    Reference materials:

    [1]https:// [2] Xinmin Weekly, Qianzhan.


    com

    [2] Xinmin Weekly, Qianzhan.
    com
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.